Efficacy and safety of cemiplimab in the treatment of advanced cutaneous squamous cell carcinoma: A multicentre real-world retrospective study from Spain and systematic review of the published data

Affiliations

• ¹ Dermatology, Complejo Asistencial Universitario de Salamanca, Salamanca, Spain.
• ² Medical Oncology, Hospital Vall d'Hebron, Barcelona, Spain.
• ³ Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
• ⁴ Departamento de Estadística, Universidad de Salamanca y Unidad de Bioestadistica del IBSAL, Salamanca, Spain.
• ⁵ Dermatology, Fundación Instituto Valenciano de Oncología (IVO), Valencia, Spain.
• ⁶ Medical Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain.
• ⁷ Medical Oncology, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
• ⁸ Dermatology Department, Hospital Clínic Barcelona, University of Barcelona, IDIBAPS, CIBERER, Barcelona, Spain.
• ⁹ Dermatology, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain.
• ¹⁰ Medical Oncology, Hospital Virgen de la Salud, Toledo, Spain.
• ¹¹ Medical Oncology, Hospital Clínico San Carlos, Madrid, Spain.
• ¹² Medical Oncology, Hospital San Pedro de Alcántara, Caceres, Spain.
• ¹³ Dermatology, Hospital Universitario Puerta del Mar, Cádiz, Spain.
• ¹⁴ Dermatology, Hospital Universitari Mútua Terrassa, Barcelona, Spain.
• ¹⁵ Medical Oncology, Hospital Universitario Clínico San Cecilio, Granada, Spain.
• ¹⁶ Medical Oncology, Complejo Asistencial Universitario de Salamanca, Salamanca, Spain.